Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC6A19 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-14 |
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-14 |
mRNA | PLPPR3 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-13 |
mRNA | ANK1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
mRNA | GAB3 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-12 |
mRNA | MTO1 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
mRNA | CD34 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-12 |
mRNA | ACSM1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
mRNA | SOCS2 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
mRNA | NFE2 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |